Suppr超能文献

慢性阻塞性肺疾病中的组织特异性极短端粒。

Tissue-Specific Ultra-Short Telomeres in Chronic Obstructive Pulmonary Disease.

机构信息

Department of Medical Genetics, Faculty of Medicine, Near East University, Nicosia, Cyprus.

Department of Molecular Biology of Genetics, Arts and Sciences Faculty, Near East University, Nicosia, Cyprus.

出版信息

Int J Chron Obstruct Pulmon Dis. 2020 Oct 30;15:2751-2757. doi: 10.2147/COPD.S267799. eCollection 2020.

Abstract

PURPOSE

Telomere biology, especially tissue-specific ultra-short telomeres, might provide a strong contribution to our current knowledge in COPD development as well as a predictive marker for prognosis. To test this hypothesis, we investigated telomere lengths in lung tissue and leukocytes in patients diagnosed with COPD.

PATIENTS AND METHODS

Thirty-two patients were included in the current study. All patients showed a post-bronchodilator ratio of less than 70% post-bronchodilator predicted value of forced expiratory volume in second (FEV1%), mean 56%; range [19% to 86%]. To be able to investigate ultra-short telomeres, universal single telomere length analysis (U-STELA) was used.

RESULTS

Our results showed a higher level of the ultra-short telomere presence in bronchoalveolar lavage (BAL) cells when compared to leukocytes with statistical significance t(62)=5.771, p<0.00001. The FEV1% was lower in subjects with ultra-short telomeres in BAL (50.6% vs 81.6%: p<0.001) and in ultra-short telomeres in blood leukocytes (37.3% vs 58.5%: p=0.051) when compared to subjects without ultra-short telomeres in leukocytes. Furthermore, the patients who had ultra-short telomeres in BAL samples were significantly older (p=0.014) than patients who did not have ultra-short telomeres. Ultra-short telomeres in BAL (p=0.05) but not in leukocytes (p=0.33) were associated with FEV1% in a regressions model adjusting for age (p<0.0001), ever smoking (p<0.0001) and sex (p=0.71). The patients with ultra-short telomeres were graded higher in the Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification (p=0.006).

CONCLUSION

This study emphasizes the need to investigate the correct tissue to get a representative evaluation of the stage or advancedness of COPD. To our knowledge, this is the first study to show that there is a correlation between the presence of ultra-short telomeres in lung tissue and COPD severity. Our results suggest that ultra-short telomeres are involved in the molecular pathogenesis of COPD and might be used as a tissue-specific predictive biomarker.

摘要

目的

端粒生物学,尤其是组织特异性极短端粒,可能为我们目前对 COPD 发展的认识以及预后的预测标志物提供重要贡献。为了验证这一假设,我们检测了诊断为 COPD 的患者的肺组织和白细胞中的端粒长度。

方法

本研究共纳入 32 名患者。所有患者均表现出支气管扩张剂后用力呼气量(FEV1%)占预计值的百分比小于 70%,平均为 56%;范围为[19%至 86%]。为了能够检测极短端粒,我们使用了通用单端粒长度分析(U-STELA)。

结果

我们的结果显示,与白细胞相比,支气管肺泡灌洗液(BAL)细胞中极短端粒的存在水平更高,差异具有统计学意义 t(62)=5.771,p<0.00001。与白细胞中没有极短端粒的患者相比,BAL 中存在极短端粒的患者的 FEV1%更低(50.6%比 81.6%:p<0.001),血液白细胞中存在极短端粒的患者的 FEV1%也更低(37.3%比 58.5%:p=0.051)。此外,BAL 样本中存在极短端粒的患者明显比没有极短端粒的患者年龄更大(p=0.014)。在调整年龄(p<0.0001)、吸烟史(p<0.0001)和性别(p=0.71)的回归模型中,BAL 中的极短端粒(p=0.05)而非白细胞中的极短端粒(p=0.33)与 FEV1%相关(p<0.0001)。极短端粒患者的 GOLD 分级更高(p=0.006)。

结论

本研究强调需要研究正确的组织,以对 COPD 的阶段或严重程度进行代表性评估。据我们所知,这是第一项表明肺组织中极短端粒的存在与 COPD 严重程度相关的研究。我们的结果表明,极短端粒参与 COPD 的分子发病机制,并且可以作为组织特异性预测生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da1b/7608580/78d0a706968e/COPD-15-2751-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验